Henry Schein, Inc.

▲ Bull Case

• ◆Cyber legal overhang resolves within insurance coverage ($150M cap, ~$50M above-insurance exposure); removes 150–250bps of implied risk premium; multiple expands from 14x to 17–18x
• ◆KKR Capstone delivers $200M+ EBIT improvement by 2027, lifting FY2027 EBIT margin to 9.5%+ (vs. 8.5% base, near pre-cyber 9.98% FY2021 peak); adj. EPS reaches $7.50–$8.50 vs. consensus $5.80
• ◆HSOne ARR disclosure at investor day reveals $750M+ ARR growing 12–15%; market re-rates software component toward dental SaaS multiples (15–20x EBITDA); sum-of-parts unlock adds $20–30/share

▼ Bear Case

• ◆Patterson Fuse cloud-native erosion accelerates, taking 5–8pp of Dentrix installed base over 3 years; HSOne ARR growth decelerates to 6–8%; compresses both HSOne premium and consolidated gross margin by 25–50bps
• ◆DSO consolidation accelerates pricing pressure: as DSOs grow to 50%+ of US dental market, HSIC's blended gross margin compresses from 35% to 33–34%; pre-tax margins decline by 100bps+
• ◆Cyber legal cost overrun: HHS HIPAA penalty + class certification + state AG settlements together exceed insurance coverage by $200M+ above base; recurring legal/monitoring costs stay at $50M+/year through FY2028; multiple stays at 13x

“Consensus debate centers on durability of HSIC's competitive moat at intersection of three secular shifts: (a) DSO consolidation (now ~40% of US dental, heading to 50%+ by 2030) creating pricing power for buyers; (b) Patterson Fuse cloud-native practice management chipping at Dentrix/Eaglesoft installed base; (c) direct-to-DSO manufacturer channels bypassing distribution in equipment. Bulls argue these shifts are multi-year (5–10y) and HSIC's HSOne software + DSO enterprise relationships create switching costs offsetting distribution erosion. Bears argue moat erosion is faster than priced and ROIC will continue compressing from 16.6% (FY2021) toward distribution-peer levels of 8–10%.”

• ◆Cyber legal resolution within insurance coverage (Q3 2026 – Q2 2027): +$0.40–0.60 EPS; multiple +1.5x; 55% probability
• ◆KKR Capstone $200M EBIT milestone (2026–2027 reporting): Path A confirmed; +$15–20/share; 45% probability
• ◆HSOne ARR disclosure at investor day (2026/2027): +$20–30 sum-of-parts unlock; 30–40% probability
• ◆Top-10 DSO enterprise HSOne win (rolling, any Q): +$5–10/share signaling; 50% probability
• ◆Strategic review / HSOne separation (2–3y horizon): +$20–35/share; 15–20% probability
• ◆Bergman succession + capable external CEO (1–2y horizon): +$10–15/share; 25% probability

• ◆Repeat cybersecurity incident (High severity, Medium probability, 1–3y): resets cyber recovery clock, suspends buybacks, triggers CISO/CIO turnover, likely credit downgrade, validates moat-erosion fears
• ◆DSO pricing compression accelerates (Medium-High severity, High probability, 2–5y): blended gross margin compresses from 35% to 33–34%; offset by HSOne software lock-in
• ◆Patterson Fuse 5pp+ Dentrix market share loss (Medium severity, High probability, 3–5y): validates moat erosion and HSOne growth compression below 7% sustainably; sub-segment SOTP unlock fails
• ◆Cyber legal cost overrun (Medium severity, Medium probability, 1–3y): HHS HIPAA penalty + class action settlement exceed insurance by $200M+; drains 1+ year FCF, suspends buybacks, downgrades credit
• ◆HHS HIPAA penalty escalation (Medium severity, Medium probability, 1–3y): regulatory tail risk larger than priced; compliance program upgrades ongoing
• ◆Bergman succession execution risk (Medium severity, Medium probability, 1–3y): no public successor designation after 35 years; transition to internal (Breslawski, age 70+) or external candidates affects strategic review pathway